Patient with recurrent grade 4 astrocytoma responding favorably to intranasal delivery of NEO100, highly pure perillyl alcohol: illustrative case
The authors present a case in which IN cancer therapy with NEO100 was well tolerated and was associated with striking tumor regression, providing further evidence that this novel conceptual approach to cancer therapy might become useful for the improved treatment of recurrent glioma. https://thejns.org/doi/10.3171/CASE24683.
Authors
- Axel H. Schönthal (ORCID: https://orcid.org/0000-0003-0662-5653)
- Rhonda Mittenzwei (ORCID: https://orcid.org/0000-0002-2471-1304)
- Frank M. Senecal
- Thomas C. Chen (ORCID: https://orcid.org/0000-0002-2183-4667)
- Stephen Swenson (ORCID: https://orcid.org/0000-0003-1366-1871)
- John L. Go
Institutions
- University of Southern California (US)
- University of California, Los Angeles (US)
- University of Washington (US)
- USC Norris Comprehensive Cancer Center (US)
- King County Medical Examiner's Office (US)
- Northwest Medical Specialties (US)
- Neurological Surgery (US)
Publication Details
- Journal
- Journal of Neurosurgery Case Lessons
- Published
- 2025-03-17
- DOI
- https://doi.org/10.3171/case24683
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00